Tag: RSV
GSK sales of RSV vaccine surpass US$1.5B on back ...
Posted by Editor | Feb 6, 2024 | LATEST NEWS, Medical Devices & Innovations, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
Officials probe rare nervous system disorder in adults who got RSV vaccine
by Editor | Mar 2, 2024 | LATEST NEWS, WORLD NEWS | 0
USA—Health officials are probing a potential connection between occurrences of a rare neurological...
Read MoreFDA accepts GSK’s Arexvy RSV vaccine expansion review for adults aged 50-59
by Editor | Feb 8, 2024 | LATEST NEWS, Science, Technology & Research, WORLD NEWS | 0
USA – The US Food and Drug Administration (FDA) has expanded the usage of GSK’s...
Read MoreGSK sales of RSV vaccine surpass US$1.5B on back of strong demand in US
by Editor | Feb 6, 2024 | LATEST NEWS, Medical Devices & Innovations, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
UK – GlaxoSmithKline (GSK) sold over US$1.5 billion worth of its recently launched...
Read MoreCDC addresses RSV drug shortage, releases 77,000 doses amid rising cases
by Editor | Nov 19, 2023 | Government, Regulatory & Policy News, LATEST NEWS, WORLD NEWS | 0
USA – In response to a critical shortage of Beyfortus, a monoclonal antibody developed by Sanofi...
Read MoreAstraZeneca’s Beyfortus faces soaring demand amidst RSV surge in U.S.
by Editor | Nov 12, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
UNITED KINGDOM — AstraZeneca has announced a strategic focus on meeting the surging demand for its...
Read MorePfizer’s Abrysvo becomes first vaccine to safeguard newborns against RSV in utero
by Editor | Aug 23, 2023 | Government, Regulatory & Policy News, LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA — In a remarkable stride toward advancing maternal and infant health, Pfizer has achieved an...
Read MoreElderly RSV vaccines set to rake in remarkable US$10.5 billion annually by 2030 in G7 Nations: Report
by Editor | Aug 16, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA —A seismic shift is on the horizon in the field of healthcare as Airfinity, the world’s...
Read MoreGSK sets high hopes on RSV Vaccine Arexvy, initiates first shipments
by Editor | Jul 27, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
UNITED KINGDOM – GSK, the UK pharmaceutical giant, is optimistic about the market prospects of its...
Read MorePfizer and GSK face intense competition in the lucrative RSV vaccine market: Report
by Editor | Jun 15, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA — A recent report indicates that pharmaceutical giants Pfizer and GSK are set to encounter...
Read MoreEuropean regulators approve first vaccine for Respiratory Syncytial Virus (RSV)
by Editor | Jun 8, 2023 | Government, Regulatory & Policy News, LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
UNITED KINGDOM —European regulators have granted approval for the first vaccine targeting...
Read MoreFDA advisers support experimental Pfizer vaccine to protect infants against RSV
by Editor | May 19, 2023 | Government, Regulatory & Policy News, LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA — Food and Drug Administration advisers have given their endorsement for administering an...
Read MoreSanofi and AstraZeneca’s RSV vaccine candidate demonstrates strong protective effect in infants
by Editor | May 14, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
UNITED KINGDOM — Sanofi and AstraZeneca have announced promising results from the Phase IIIb...
Read More